Browsing Technical documents and research evidence on COVID-19 by Subject "Receptor, Angiotensin, Type 1"
Now showing items 1-1 of 1
ACE inhibitors, AT1 receptor blockers and COVID-19: clinical epidemiology evidences for a continuation of treatments. The ACER-COVID study (2020-05-01)Aims: The question of interactions between the renin angiotensin aldosterone system drugs and the incidence and prognosis of COVID-19 infection has been raised by the medical community. We hypothesised that if patients ...